C1ORF58 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 7.86929965634897E-10 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.57619999996417E-06 |
Normal-vs-Stage2 |
1.598850E-04 |
Normal-vs-Stage3 |
7.50600026577786E-10 |
Normal-vs-Stage4 |
2.69050337564636E-11 |
Stage1-vs-Stage2 |
6.296600E-01 |
Stage1-vs-Stage3 |
2.797200E-03 |
Stage1-vs-Stage4 |
2.971100E-04 |
Stage2-vs-Stage3 |
1.226570E-01 |
Stage2-vs-Stage4 |
2.700300E-02 |
Stage3-vs-Stage4 |
4.057400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
4.38280001180402E-09 |
Normal-vs-AfricanAmerican |
4.43910019853888E-10 |
Normal-vs-Asian |
3.177400E-01 |
Caucasian-vs-AfricanAmerican |
1.105910E-02 |
Caucasian-vs-Asian |
2.795800E-01 |
AfricanAmerican-vs-Asian |
3.512300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
8.61300031296253E-10 |
Normal-vs-Female |
1.55049999950307E-07 |
Male-vs-Female |
3.529800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
3.033900E-04 |
Normal-vs-Age(41-60Yrs) |
1.32369999961135E-07 |
Normal-vs-Age(61-80Yrs) |
1.12499998206061E-09 |
Normal-vs-Age(81-100Yrs) |
1.584040E-04 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.498000E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.707600E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.073200E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.048000E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.697200E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.196200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
4.837200E-01 |
Normal-vs-Grade 2 |
8.56570000040691E-07 |
Normal-vs-Grade 3 |
9.44920031109575E-10 |
Normal-vs-Grade 4 |
4.20419254965054E-12 |
Grade 1-vs-Grade 2 |
1.013360E-01 |
Grade 1-vs-Grade 3 |
2.101600E-02 |
Grade 1-vs-Grade 4 |
6.582400E-04 |
Grade 2-vs-Grade 3 |
4.525700E-02 |
Grade 2-vs-Grade 4 |
1.230740E-04 |
Grade 3-vs-Grade 4 |
1.930360E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
4.836600E-04 |
Normal-vs-ccB subtype |
9.2937000317761E-09 |
ccA subtype-vs-ccB subtype |
3.356200E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
2.99410000126343E-08 |
Normal-vs-N1 |
2.197600E-01 |
N0-vs-N1 |
7.189600E-01 |
|
|